Bioscience Animal Health PCL (BKK:BIS)
Thailand flag Thailand · Delayed Price · Currency is THB
1.900
0.00 (0.00%)
Feb 5, 2026, 4:36 PM ICT

BKK:BIS Income Statement

Millions THB. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
2,2692,3242,4122,1941,9751,760
Other Revenue
50.8250.8214.5218.8611.4821.51
2,3192,3742,4272,2131,9861,782
Revenue Growth (YoY)
-3.10%-2.16%9.65%11.43%11.47%-5.26%
Cost of Revenue
1,9261,9782,0801,8771,6281,442
Gross Profit
393.35396.56347.32335.81358.34340.19
Selling, General & Admin
286.22291.02279.03260.17262.37251.89
Other Operating Expenses
18.5110.71----
Operating Expenses
304.72301.72279.03260.17262.37261.71
Operating Income
88.6394.8468.2975.6395.9778.47
Interest Expense
-1.92-2.63-1.89-6.27-9.94-9.07
Interest & Investment Income
-----1.16
Earnings From Equity Investments
----0.33.37
Currency Exchange Gain (Loss)
-----0.7
EBT Excluding Unusual Items
86.7192.2166.469.3786.3374.63
Gain (Loss) on Sale of Investments
----0.27-1.49
Gain (Loss) on Sale of Assets
---6.4--
Pretax Income
86.7192.2166.475.7786.673.14
Income Tax Expense
16.8120.5513.5216.0917.9718.7
Earnings From Continuing Operations
69.9171.6652.8859.6768.6254.45
Minority Interest in Earnings
-4.86-6.62-2.18-3.763.787.79
Net Income
65.0565.0450.7155.9272.462.23
Net Income to Common
65.0565.0450.7155.9272.462.23
Net Income Growth
3.80%28.27%-9.32%-22.77%16.34%110.70%
Shares Outstanding (Basic)
314314314284220176
Shares Outstanding (Diluted)
314314314284220176
Shares Change (YoY)
--10.71%28.91%25.24%9.79%
EPS (Basic)
0.210.210.160.200.330.35
EPS (Diluted)
0.210.210.160.200.330.35
EPS Growth
3.80%28.27%-18.09%-40.09%-7.11%91.92%
Free Cash Flow
277.9898.5-28.66-47.2518.49-1.86
Free Cash Flow Per Share
0.890.31-0.09-0.170.08-0.01
Dividend Per Share
0.1700.1400.1100.1220.4100.138
Dividend Growth
41.67%27.27%-10.20%-70.12%198.18%-78.28%
Gross Margin
16.96%16.70%14.31%15.17%18.04%19.09%
Operating Margin
3.82%3.99%2.81%3.42%4.83%4.40%
Profit Margin
2.80%2.74%2.09%2.53%3.65%3.49%
Free Cash Flow Margin
11.98%4.15%-1.18%-2.14%0.93%-0.10%
EBITDA
103.75107.7980.5687.92108.4190.45
EBITDA Margin
4.47%4.54%3.32%3.97%5.46%5.08%
D&A For EBITDA
15.1312.9512.2712.2912.4411.98
EBIT
88.6394.8468.2975.6395.9778.47
EBIT Margin
3.82%3.99%2.81%3.42%4.83%4.40%
Effective Tax Rate
19.38%22.29%20.36%21.24%20.75%25.56%
Revenue as Reported
2,3182,3742,4272,2201,9871,784
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.